Sponsor or institution

Clinical trials and research at Pharming Technologies B.V.

• 2Clinical trials
• 11Countries

All recruiting trials (2)

• Open-label extension to test KL1333 long-term safety and benefit for primary mitochondrial disease

  This extension study will see if KL1333 can be safely used long-term and whether it helps reduce fatigue and improve daily living in adults with primary mitochondrial disease who previously took KL1333 or placebo.

  Recruiting at 23 sites Phase 2 Pharming Technologies B.V. · Akron, Ohio and 22 other locations · NCT07514338

• Evaluating KL1333 for treating primary mitochondrial disease

  This study is testing if a new drug called KL1333 can help adults with primary mitochondrial disease feel less tired and improve their physical abilities over 48 weeks.

  Recruiting at 37 sites Phase 2 Pharming Technologies B.V. · Orange, California and 54 other locations · NCT05650229

Quick answers

How many clinical trials run by Pharming Technologies B.V. are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 11 countries. The most sites are in Belgium (2 trials), Czechia (2 trials), Denmark (2 trials), France (2 trials), Germany (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →